Shitao Feng, An Zhang, Fengshou Wu, Xiaogang Luo & Juan Zhang. (2022) In-situ growth of boronic acid-decorated metal-organic framework on Fe3O4 nanospheres for specific enrichment of cis-diol containing nucleosides. Analytica Chimica Acta 1206, pages 339772.
Crossref
Anna Mikulska, Masamichi Inoue, Keita Kuroda, Agnieszka Iwanowska, Shin-Ichi Yusa, Maria Nowakowska & Krzysztof Szczubia?ka. (2014) Polymeric/silicagel hybrid molecularly photoimprinted adsorbents for adenosine and its derivatives. European Polymer Journal 59, pages 230-238.
Crossref
Charles W. Gehrke & David S. Hage. 2010. Chromatography. Chromatography
269
322
.
Paolo Iadarola, Giuseppe Cetta, Maurizio Luisetti, Laura Annovazzi, Begona Casado, James Baraniuk, Chiara Zanone & Simona Viglio. (2005) Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: A critical review of the state‐of‐the‐art. ELECTROPHORESIS 26:4-5, pages 752-766.
Crossref
Yinfa Ma, Guanshu Liu, Ming Du & Isaac Stayton. (2004) Recent developments in the determination of urinary cancer biomarkers by capillary electrophoresis. ELECTROPHORESIS 25:10-11, pages 1473-1484.
Crossref
Sookie La, JungHwan Cho, Jung-Han Kim & Kyoung-Rae Kim. (2003) Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients. Analytica Chimica Acta 486:2, pages 171-182.
Crossref
C.W. Gehrke & K.C. Kuo. 2000. Encyclopedia of Separation Science. Encyclopedia of Separation Science
3528
3543
.
G Xu, C Di Stefano, H.M Liebich, Y Zhang & P Lu. (1999) Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients. Journal of Chromatography B: Biomedical Sciences and Applications 732:2, pages 307-313.
Crossref
Glenn R. Björk & Torgny Rasmuson. 1998. Modification and Editing of RNA. Modification and Editing of RNA
471
491
.
H.M Liebich, G Xu, C Di Stefano & R Lehmann. (1998) Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Journal of Chromatography A 793:2, pages 341-347.
Crossref
Karl H. Schram. (1998) Urinary nucleosides. Mass Spectrometry Reviews 17:3, pages 131-251.
Crossref
J. P. Buchet, M. Ferreira, J. B. Burrion, T. Leroy, M. Kirsch‐Volders, P. Van Hummelen, J. Jacques, L. Cupers, J. P. Delavignette & R. Lauwerys. (2007) Tumor markers in serum, polyamines and modified nucleosides in urine, and cytogenetic aberrations in lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. American Journal of Industrial Medicine 27:4, pages 523-543.
Crossref
Christopher C. Marvel, John Del Rowe, Eric G. Bremer & Joseph R. Moskal. (1994) Altered RNA turnover in carcinogenesis. Molecular and chemical neuropathology 21:2-3, pages 353-368.
Crossref
Masayuki Masuda, Tetsuro Nishihira, Kunihiko Itoh, Michinao Mizugaki, Nakao Ishida & Shozo Mori. (1993) An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides. Cancer 72:12, pages 3571-3578.
Crossref
Fabrizio Pane, Marcella Savoia, Giuliana Fortunato, Andrea Camera, Bruno Rotoli, Francesco Salvatore & Lucia Sacchetti. (1993) Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia. Clinical Biochemistry 26:6, pages 513-520.
Crossref
Yongtian Li, Shaoshen Wang & Ning Zhong. (2005) Simultaneous determination of pseudouridine and creatinine in urine of normal children and patients with leukaemia by high performance liquid chromatography. Biomedical Chromatography 6:4, pages 191-193.
Crossref
C. Reynaud, C. Bruno, P. Boullanger, J. Grange, S. Barbesti & A. Niveleau. (1992) Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies. Cancer Letters 61:3, pages 255-262.
Crossref
S.M. D'Ambrosio, R.E. Gibson-D'Ambrosio & R.W. Trewyn. (1991) An enzyme-linked immunosorbent assay (ELISA) for the detection and quantitation of the tumor marker 1-methylinosine in human urine. Clinica Chimica Acta 199:2, pages 119-128.
Crossref
Opendra K. Sharma & Alf Fischbein. 1990. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications
C321
C340
.
Kenneth C. Kuo, Dat T. Phan, Nathan Williams & Charles W. Gehrke. 1990. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications
C41
C113
.
Robert W. Zumwalt, T. Phillip Waalkes, Kenneth C. Kuo & Charles W. Gehrke. 1990. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications
C15
C40
.
T. Phillip Waalkes & Charles W. Gehrke. 1990. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications. Chromatography and Modification of Nucleosides - Modified Nucleosides in Cancer and Normal Metabolism Methods and Applications
C1
C13
.
Edith F. Yamasaki, Altaf A. Wani & Ronald W. Trewyn. 1990. Chromatography and Modification of Nucleosides - Biological Roles and Function of Modification. Chromatography and Modification of Nucleosides - Biological Roles and Function of Modification
B125
B142
.